Other strategies in an animal model have demonstrated the efficacy of therapeutic lymphangiogenesis against lymphedema to increase or supplement the growth factors or peptides such as HGF [123], Adrenomedullin [124], bFGF [125], and Angiopoetin-1 [126]. The gene discussed is HGF; the disease is lymphedema.